tirzepatide death linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s The SURMOUNT-MMO trial is underway
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
The SURMOUNT MMO trial is underway to test if #tirzepatide can reduce heart attacks, strokes, heart failure, and death in adults with obesity. This global study will enroll ~15,000 people at risk for How the weight loss drug tirzepatide is also helping heart failure patients AHA 2024 Tirzepatide lowers the risk of worsening heart failure and CVD death for obese adults Medical Update Online Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT 1 randomised controlled trial Heart Effects of tirzepatide on circulatory overload and end organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial Nature Medicine Tirzepatide linked to lower risk of death in people with type 2 diabetes
Store: jftbasic.com · Domain: jftbasic.com
